Farouji Abdelhadi, Hellou Rabea, Peretz Asaf
Internal Medicine, Assuta Ashdod Medical Center, Ben-Gurion University of the Negev, Ashdod, ISR.
Cureus. 2021 Sep 17;13(9):e18039. doi: 10.7759/cureus.18039. eCollection 2021 Sep.
The novel coronavirus disease 2019 (COVID-19) is an ongoing pandemic. Although COVID-19 is frequently associated with respiratory symptoms and complications, multiple extrapulmonary manifestations have been identified since the beginning of the pandemic. Rhabdomyolysis has been described in the literature as one of the extrapulmonary manifestations of COVID-19. Herein, we describe a 21-year-old male patient who presented with cough and fever secondary to COVID-19 confirmed by positive reverse-transcription polymerase chain reaction (RT-PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The patient presented with an extremely elevated creatinine kinase (CK) of 53,886 U/L (normal 10-170) without any classical symptoms of rhabdomyolysis or deterioration in his kidney function. He was successfully managed with aggressive intravenous fluids. The aim of reporting this case is to highlight the importance of including total CK in the initial evaluation of COVID-19 patients.
2019年新型冠状病毒病（COVID-19）是一场持续的大流行病。尽管COVID-19常与呼吸道症状及并发症相关，但自疫情开始以来已发现多种肺外表现。横纹肌溶解症在文献中被描述为COVID-19的肺外表现之一。在此，我们描述一名21岁男性患者，他因严重急性呼吸综合征冠状病毒2（SARS-CoV-2）逆转录聚合酶链反应（RT-PCR）呈阳性而确诊为COVID-19，继发咳嗽和发热。该患者肌酸激酶（CK）极度升高至53886 U/L（正常范围10 - 170），却无任何横纹肌溶解的典型症状或肾功能恶化。通过积极静脉补液，他得到了成功治疗。报告此病例的目的是强调在COVID-19患者初始评估中纳入总CK的重要性。
